Clinical Trials in Phoenix

Showing 10221-10240 of 12,606 trials

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

NCT00022074

RATIONALE: Gabapentin may be effective for the control of hot flashes. It is not yet known if gabapentin is effective in treating hot flashes. PURPOSE: Randomized clinical trial to study the effectiveness of gabapentin in controlling hot flashes in women who have breast cancer.

Anxiety DisorderBreast CancerDepression+1 more

Gary MorrowStarted Jul 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +15 more locations

COMPLETEDPhase 3< 1 mile

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

NCT00020657

RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer.

Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific

Gary MorrowStarted Jul 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +12 more locations

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Find Trials by Condition in Phoenix

Pioglitazone in Early Parkinson's Disease

Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Essential Tremor

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

PoC in Rheumatoid Arthritis With Methotrexate

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Self Selection Trial of Naproxen Sodium

A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

Ph IIA Study (SOC +/- NS5B)

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy

Phase II, 2nd Line Melanoma - RAND Monotherapy

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer